Simplex Trading’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.1K Sell
439
-912
-68% -$26.8K ﹤0.01% 7356
2026
Q1
$41.8K Sell
1,351
-7,791
-85% -$192K ﹤0.01% 6065
2025
Q4
$191K Buy
9,142
+8,374
+1,090% +$156K ﹤0.01% 4282
2025
Q3
$12K Buy
+768
New +$15.8K ﹤0.01% 7787
2023
Q2
– Sell
-60
Closed -$678 – 10131
2023
Q1
$0 Buy
+60
New +$835 ﹤0.01% 10323
2022
Q3
– Sell
-21
Closed – – 11059
2022
Q2
$0 Sell
21
-158
-88% -$1.86K ﹤0.01% 11310
2022
Q1
$2K Buy
+179
New +$3.7K ﹤0.01% 9967
2021
Q2
– Sell
-476
Closed -$56.4K – 10831
2021
Q1
$72K Buy
476
+425
+833% +$69.1K ﹤0.01% 6180
2020
Q4
$8K Buy
51
+6
+13% +$1.07K ﹤0.01% 7550
2020
Q3
$7K Buy
+45
New +$9.07K ﹤0.01% 6982

Other funds holding TECX

Simplex Trading's TECX Position: Q2 2026 in Review

Simplex Trading reduced its Tectonic Therapeutic (TECX) stake by 68% in Q2 2026, selling an estimated $26.8K and leaving 439 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7356.

Simplex Trading first reported a position in TECX in Q3 2020 and has held it in 10 quarters since. The position peaked at $191K in Q4 2025. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Simplex Trading held 439 shares of Tectonic Therapeutic worth $15.1K as of Q2 2026.
  • Simplex Trading sold 912 Tectonic Therapeutic shares in Q2 2026, an estimated $26.8K.
  • Tectonic Therapeutic made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7356 holding.
  • Simplex Trading first reported a position in Tectonic Therapeutic in Q3 2020 and has held it in 10 quarters since.
  • Simplex Trading's Tectonic Therapeutic position peaked at $191K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.